Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05464173 | Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib(CINDERELLA) | unknown | Phase 1 / Phase 2 | 44 | Biyun Wang, MDOTHER | 1 | Jan 22, 2024 | clinicaltrials |
| NCT06210347 | Patterns of Relapse After Neoadjuvant Chemotherapy in Breast Cancer | unknown | — | 50 | Assiut UniversityOTHER | 0 | Jan 18, 2024 |
| clinicaltrials |
| NCT06210438 | SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases | unknown | Phase 2 | 24 | Fudan UniversityOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT06210529 | Clinical Study of High-intensity Focused Ultrasound Tumor Treatment System(Super Knife) in the Treatment of Breast Cancer | unknown | N/A | 12 | Shengjing HospitalOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT05629429 | Olaparib Maintenance Therapy in Metastatic Breast Cancer | unknown | Phase 2 | 300 | National Taiwan University HospitalOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT05954442 | Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype(BCTOP-T-M03) | unknown | Phase 3 | 203 | Fudan UniversityOTHER | 1 | Jan 16, 2024 | clinicaltrials |
| NCT06206395 | Role of Multi-modality Imaging in the Assessment of Chemotherapy Related Cardiac Dysfunction Among Cancer Patients | unknown | — | 190 | Assiut UniversityOTHER | 1 | Jan 16, 2024 | clinicaltrials |
| NCT03260192 | Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer | unknown | — | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT06195202 | Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS) | unknown | — | 2,000 | Sun Yat-sen UniversityOTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06194565 | 99mTc-ABH2 SPECT/CT in Breast Cancer | unknown | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT06152419 | Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project | unknown | N/A | 25 | University Hospital, GhentOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT05142202 | High Five (HiFi) Accelerated Partial Breast Irradiation Study(HiFi) | unknown | N/A | 147 | The Greater Poland Cancer CentreOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT05574907 | Characterizing Breast Cancer With 68Ga-FAPI PET/CT (PFB-01) | unknown | N/A | 72 | Peking Union Medical College HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT05574920 | Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02) | unknown | N/A | 88 | Peking Union Medical College HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT06185855 | A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in Ultrasonography | unknown | — | 550 | RenJi HospitalOTHER | 0 | Dec 29, 2023 | clinicaltrials |
| NCT06186011 | Quality of Life and Cosmetic Outcomes of Breast-Conserving Surgery According to Localization Method(TRIGUIDE) | unknown | N/A | 150 | Hospital Clinic of BarcelonaOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT02473003 | Physical Training and Cancer-a Multicenter Clinical Trial(Phys-Can) | unknown | N/A | 600 | Uppsala UniversityOTHER | 0 | Dec 21, 2023 | clinicaltrials |
| NCT06169007 | Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer | unknown | — | 84 | Assiut UniversityOTHER | 0 | Dec 20, 2023 | clinicaltrials |
| NCT03812393 | Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast(FACT-2) | unknown | Phase 2 | 27 | West Cancer CenterOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT04197687 | TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery | unknown | Phase 2 | 480 | Academic and Community Cancer Research UnitedOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT06174571 | Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. | unknown | — | 90 | Assiut UniversityOTHER | 0 | Dec 18, 2023 | clinicaltrials |
| NCT04574609 | Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.(HYGEE) | unknown | N/A | 27 | Fondation Hôpital Saint-JosephOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT05673694 | To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer. | unknown | Phase 1 | 70 | Changchun GeneScience Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 14, 2023 | clinicaltrials |
| NCT05247463 | English Mammography Screening Outcomes by Age, Frequency and Test Threshold(ATHENA-M) | unknown | — | 10,000,000 | University of WarwickOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT06166173 | Using Color Doppler US Artifact to Identify Tumor Markers | unknown | — | 60 | Istanbul Medeniyet UniversityOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT04974567 | Tear Based Sample Collection Breast Cancer Detection | unknown | — | 50 | Namida LabINDUSTRY | 1 | Dec 11, 2023 | clinicaltrials |
| NCT06158217 | Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer | unknown | — | 30 | Beijing Friendship HospitalOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT04450732 | Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors | unknown | Phase 1 | 96 | GeneQuantum Healthcare (Suzhou) Co., Ltd.INDUSTRY | 3 | Dec 5, 2023 | clinicaltrials |
| NCT06156761 | Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer | unknown | N/A | 24 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT05523609 | Vitamin D and Calcium Supplementation in Breast Cancer | unknown | Phase 2 / Phase 3 | 40 | Tanta UniversityOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06154109 | Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial | unknown | Phase 2 | 90 | Zhiyu WangOTHER | 0 | Dec 1, 2023 | clinicaltrials |
| NCT06151249 | Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy | unknown | Phase 2 | 32 | Chung Shan Medical UniversityOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT06152471 | Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer(ASF-BC) | unknown | Phase 3 | 100 | Henrik LindmanOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT06149611 | Mass Balance Study of TQB3616 | unknown | Phase 1 | 8 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Nov 29, 2023 | clinicaltrials |
| NCT04713917 | Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment(EPIONE-01) | unknown | N/A | 330 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05409352 | Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy | unknown | N/A | 138 | The University of Hong KongOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05792475 | Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes | unknown | N/A | 3 | TaiHao Medical Inc.INDUSTRY | 1 | Nov 27, 2023 | clinicaltrials |
| NCT03906669 | A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.(WinPro) | unknown | Phase 2 | 200 | St Vincent's HospitalOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06133959 | Healthy ME: Advancing Health Equity in Lymphatic Pain and Lymphedema in Black and Hispanic Women With Breast Cancer(HealthyME) | unknown | N/A | 60 | University of Missouri, Kansas CityOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT06142344 | Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients(HoLiBreast) | unknown | N/A | 13 | The Netherlands Cancer InstituteOTHER | 2 | Nov 21, 2023 | clinicaltrials |
| NCT06134570 | ALDH1A1 Expression in Invasive Mammary Carcinoma | unknown | — | 60 | Sohag UniversityOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT06135194 | Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib | unknown | — | 30 | Beijing 302 HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT03926091 | Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer(CLOVER) | unknown | Phase 3 | 2,172 | Fudan UniversityOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT06130111 | Spatial Location of Breast Cancer Local Recurrence After Mastectomy(Secret) | unknown | — | 170 | Maastricht Radiation OncologyOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02284581 | Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments(BIO-META) | unknown | — | 10,000 | Consorzio OncotechOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT05453604 | Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications(URODETECT-WP1) | unknown | N/A | 105 | Novosanis NVINDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06129786 | Overcoming Therapy Resistance in ER+ Breast Cancer Patients: a Translational Project (OVERTuRE)(OVERTuRE) | unknown | — | 74 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06123819 | Shear-wave Elastography in Breast Cancer | unknown | — | 60 | Assiut UniversityOTHER | 0 | Nov 9, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jan 22, 2024source: clinicaltrials